The Food and Drug Administration approved the first needle-free alternative to the EpiPen on Friday, a single-use epinephrine nasal spray for the emergency treatment of allergic reactions, including ...
A multicenter study found that a 2-hour monitoring period was sufficient for most children who presented to the emergency department with an acute allergic reaction treated with epinephrine. However, ...
The Food and Drug Administration has declined to approve an alternative to epinephrine autoinjectors such as EpiPens, telling the maker of a nasal spray that more study is required. ARS Pharma, maker ...
neffy is a nasal spray used for emergency treatment of allergic reactions including anaphylaxis, in adults and children aged 4 years and older who weigh 33 lbs. or greater. INDICATION AND IMPORTANT ...
IMPORTANT SAFETY INFORMATION neffy contains epinephrine, a medicine used to treat allergic emergencies (anaphylaxis). Anaphylaxis can be life-threatening, can happen in minutes, and can be caused by ...
The US Food and Drug Administration on Tuesday did not approve a needle-free epinephrine for treatment of severe allergic reactions, a move that drugmaker ARS Pharmaceuticals called surprising.
Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS Pharmaceuticals received the green light from health regulators for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback